Microbot Medical Inc., announced that the United States Patent and Trade Office has issued a Notice of Allowance covering the Company’s LIBERTY® Robotic System. Globally, the Company now has 45 patents issued/allowed and 24 pending patent applications.
“This achievement is yet another meaningful milestone that adds a secure foundation to build our sustainable competitive advantage. This IP allows us to protect our assets globally and advance towards commercialization,” commented Harel Gadot, CEO, President and Chairman. “We believe our novel technology is uniquely positioned to transform catheter-based procedures and benefit more patients globally while keeping physicians safe from radiation and reducing their physical strain.”
Recommended AI News: Docufree Named A Global Leader In Cloud Computing
The allowed patent pertains to a device for automatically inserting and manipulating a medical tool into and within a bodily lumen. The allowed claims cover a compact robotic drive for driving and manipulating movement of at least one elongate surgical tool, the robotic drive includes a housing comprising motors and a first tool-moving element driven by the motors, positioned and configured to advance or retract the elongate surgical tool, and a second tool-moving element driven by the motors, configured to roll the elongate surgical tool about the long axis.
Recommended AI News: BetterCloud And VMware To Fuel The SaaS-Powered Digital Workplace
Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot’s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).
Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies.
Recommended AI News: Bandwidth Issues Statement On Recent DDoS Attack
To share your insights with us, please write to sghosh@martechseries.com
Comments are closed.